{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:04:54Z","timestamp":1784934294561,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["NU22-08-00287"],"award-info":[{"award-number":["NU22-08-00287"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["CZ.02.01.01\/00\/23_015\/0008208"],"award-info":[{"award-number":["CZ.02.01.01\/00\/23_015\/0008208"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CZ.02.1.01\/0.0\/0.0\/16_025\/0007428"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/16_025\/0007428"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031822","name":"CSIR - Institute of Himalayan Bioresource Technology","doi-asserted-by":"publisher","award":["00023736"],"award-info":[{"award-number":["00023736"]}],"id":[{"id":"10.13039\/100031822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jcyt.2026.102077","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T19:06:21Z","timestamp":1769713581000},"page":"102077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advancing acute myeloid leukemia immunotherapy: transcriptomic profiling-guided donor selection combined with an innovative natural killer cell expansion protocol"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5954-5191","authenticated-orcid":false,"given":"Eva","family":"Ma\u0161\u00ednov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Papatheodorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5391-1131","authenticated-orcid":false,"given":"Veronika","family":"\u0160vubov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate\u0159ina","family":"Kuglerov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7010-4073","authenticated-orcid":false,"given":"Marek","family":"Jedli\u010dka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7767-1003","authenticated-orcid":false,"given":"Kamila","family":"Bend\u00ed\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Hortov\u00e1 Kouhoutkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4198-5630","authenticated-orcid":false,"given":"Petr","family":"Lesn\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4274-3895","authenticated-orcid":false,"given":"Jan","family":"Vydra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6642-797X","authenticated-orcid":false,"given":"Jan","family":"Fri\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2026.102077_bib0001","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2026.102077_bib0002","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.exphem.2007.12.006","article-title":"Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation","volume":"36","author":"Schulze","year":"2008","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jcyt.2026.102077_bib0003","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1158\/1078-0432.CCR-17-3196","article-title":"Complete remission with reduction of high-risk clones following haploidentical NK-cell therapy against MDS and AML","volume":"24","author":"Bjorklund","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcyt.2026.102077_bib0004","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","article-title":"Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer","volume":"105","author":"Miller","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102077_bib0005","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.bbmt.2016.04.009","article-title":"Haploidentical natural killer cells infused before allogeneic stem cell transplantation for myeloid malignancies: a phase I trial","volume":"22","author":"Lee","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2026.102077_bib0006","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1158\/1078-0432.CCR-15-1604","article-title":"Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients","volume":"22","author":"Curti","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcyt.2026.102077_bib0007","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fonc.2013.00118","article-title":"Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol","volume":"3","author":"Koehl","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.jcyt.2026.102077_bib0008","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/JLB.5MIR0420-055R","article-title":"Roles of IL-2 in bridging adaptive and innate immunity, and as a tool for cellular immunotherapy","volume":"108","author":"Bendickova","year":"2020","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jcyt.2026.102077_bib0009","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jcyt.2020.12.002","article-title":"Generating natural killer cells for adoptive transfer: expanding horizons","volume":"23","author":"Kundu","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2026.102077_bib0010","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.bbmt.2016.08.008","article-title":"Donor-derived natural killer cell infusion after human leukocyte antigen\u2013haploidentical hematopoietic cell transplantation in patients with refractory acute leukemia","volume":"22","author":"Choi","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2026.102077_bib0011","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00262-010-0904-3","article-title":"A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer","volume":"59","author":"Iliopoulou","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jcyt.2026.102077_bib0012","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41375-023-01849-5","article-title":"The infusion of ex vivo, interleukin-15 and -21-activated donor NK cells after haploidentical HCT in high-risk AML and MDS patients\u2014a randomized trial","volume":"37","author":"Lee","year":"2023","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.jcyt.2026.102077_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027351","article-title":"IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I\/II study","volume":"6","author":"Brehm","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2026.102077_bib0014","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2017-05-785659","article-title":"Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation","volume":"130","author":"Ciurea","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102077_bib0015","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1038\/s41467-020-19094-0","article-title":"Cryopreservation impairs 3-D migration and cytotoxicity of natural killer cells","volume":"11","author":"Mark","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcyt.2026.102077_bib0016","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jcyt.2020.05.001","article-title":"Analysis of ex vivo expanded and activated clinical-grade human NK cells after cryopreservation","volume":"22","author":"Damodharan","year":"2020","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2026.102077_bib0017","article-title":"Bioinspired preservation of natural killer cells for cancer immunotherapy","volume":"6","author":"El Assal","year":"2019","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jcyt.2026.102077_bib0018","article-title":"Bulk and single-cell transcriptomics identify gene signatures of stem cell-derived NK cell donors with superior cytolytic activity","volume":"32","author":"van Vliet","year":"2024","journal-title":"Mol Ther Oncol"},{"key":"10.1016\/j.jcyt.2026.102077_bib0019","doi-asserted-by":"crossref","first-page":"e1151","DOI":"10.1002\/cti2.1151","article-title":"Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B- and T-cell acute lymphoblastic leukaemia","volume":"9","author":"Foley","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.jcyt.2026.102077_bib0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/bmt.2012.162","article-title":"Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers","volume":"48","author":"Stern","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2026.102077_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-019-0564-6","article-title":"A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia","volume":"7","author":"Nguyen","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jcyt.2026.102077_bib0022","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/CJI.0000000000000250","article-title":"Natural killer cell homing and persistence in the bone marrow after adoptive immunotherapy correlates with better leukemia control","volume":"42","author":"Grzywacz","year":"2019","journal-title":"J Immunother"},{"key":"10.1016\/j.jcyt.2026.102077_bib0023","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12950-025-00470-w","article-title":"Glutaminase activity maintains NK cell cytotoxicity through metabolic regulation of effector function","volume":"22","author":"Jedli\u010dka","year":"2025","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.jcyt.2026.102077_bib0024","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcyt.2026.102077_bib0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2014a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jcyt.2026.102077_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v025.i01","article-title":"FactoMineR: an R package for multivariate analysis","volume":"25","author":"L\u00ea","year":"2008","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jcyt.2026.102077_bib0027","unstructured":"Kassambara A, Mundt F. Package: factoextra (via r-universe) type package title extract and visualize the results of multivariate data analyses. 2020. Rpackage version 1.0.7, https:\/\/cean.r-project.org"},{"key":"10.1016\/j.jcyt.2026.102077_bib0028","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.jcyt.2026.102077_bib0029","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"10.1016\/j.jcyt.2026.102077_bib0030","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jcyt.2026.102077_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.706907","article-title":"ggVennDiagram: an intuitive, easy-to-use, and highly customizable R package to generate Venn diagram","volume":"12","author":"Gao","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.jcyt.2026.102077_bib0032","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fcimb.2020.00049","article-title":"Characterizing the dysfunctional NK cell: assessing the clinical relevance of exhaustion, anergy, and senescence","volume":"10","author":"Judge","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jcyt.2026.102077_bib0033","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1172\/JCI125916","article-title":"Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming","volume":"129","author":"Merino","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcyt.2026.102077_bib0034","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/978-1-4939-3684-7_29","article-title":"Regulatory considerations for NK cells used in human immunotherapy applications","volume":"1441","author":"Lee","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jcyt.2026.102077_bib0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0022-1759(93)90102-D","article-title":"Human natural killer cells: a convenient purification procedure and the influence of cryopreservation on cytotoxic activity","volume":"165","author":"Voshol","year":"1993","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jcyt.2026.102077_bib0036","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.4110\/in.2018.18.e31","article-title":"Optimization of large-scale expansion and cryopreservation of human natural killer cells for anti-tumor therapy","volume":"18","author":"Min","year":"2018","journal-title":"Immune Netw"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102077_bib0037","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1038\/s41467-024-47574-0","article-title":"Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservation","volume":"15","author":"Berjis","year":"2024","journal-title":"Nat Commun"},{"issue":"42","key":"10.1016\/j.jcyt.2026.102077_bib0038","doi-asserted-by":"crossref","DOI":"10.1002\/advs.72370","article-title":"Restoring NK cell cytotoxicity post-cryopreservation via synthetic cells","volume":"12","author":"Zhou","year":"2025","journal-title":"Adv Sci"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102077_bib0039","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-78619-5","article-title":"Effect of NK cell receptor genetic variation on allogeneic stem cell transplantation outcome and in vitro NK cell cytotoxicity","volume":"14","author":"Nihtil\u00e4","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2026.102077_bib0040","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1115178","article-title":"Advances in clinical NK cell studies: donor selection, manufacturing and quality control","volume":"5","author":"Koehl","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jcyt.2026.102077_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1111419","article-title":"Donor selection for adoptive immunotherapy with NK cells in AML patients: comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire","volume":"14","author":"Meazza","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2026.102077_bib0042","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00262-016-1792-y","article-title":"Selection and expansion of natural killer cells for NK cell-based immunotherapy","volume":"65","author":"Becker","year":"2016","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jcyt.2026.102077_bib0043","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1139\/bcb-2023-0369","article-title":"Distinct domain organization and diversity of 2\u2019-5\u2019-oligoadenylate synthetases","volume":"102","author":"Koul","year":"2024","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.jcyt.2026.102077_bib0044","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fimmu.2017.00304","article-title":"Type I interferons and natural killer cell regulation in cancer","volume":"8","author":"M\u00fcller","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2026.102077_bib0045","first-page":"694","article-title":"STATs in NK-cells: the good, the bad, and the ugly","volume":"7","author":"Gotthardt","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2026.102077_bib0046","article-title":"Role of GBP1 in innate immunity and potential as a tuberculosis biomarker","volume":"12","author":"Shi","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2026.102077_bib0047","article-title":"IFIT3: a crucial mediator in innate immunity and tumor progression with therapeutic implications","volume":"16","author":"Wu","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2026.102077_bib0048","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","article-title":"The P2X7 receptor in infection and inflammation","volume":"47","author":"Di Virgilio","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.jcyt.2026.102077_bib0049","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/MCB.00879-12","article-title":"Ribosomal protein S25 dependency reveals a common mechanism for diverse internal ribosome entry sites and ribosome shunting","volume":"33","author":"Hertz","year":"2013","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jcyt.2026.102077_bib0050","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1238543","article-title":"Deficiency of the adaptor protein SLy1 results in a natural killer cell ribosomopathy affecting tumor clearance","volume":"5","author":"Arefanian","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jcyt.2026.102077_bib0051","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5483\/BMBRep.2022.55.8.092","article-title":"Emerging role of anti-proliferative protein BTG1 and BTG2","volume":"55","author":"Kim","year":"2022","journal-title":"BMB Rep"},{"key":"10.1016\/j.jcyt.2026.102077_bib0052","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41591-023-02785-8","article-title":"Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1\/2 trial","volume":"30","author":"Marin","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2026.102077_bib0053","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fcimb.2017.00435","article-title":"Rab GTPases in immunity and inflammation","volume":"7","author":"Prashar","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jcyt.2026.102077_bib0054","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1002\/eji.201141582","article-title":"VAMP4- and VAMP7-expressing vesicles are both required for cytotoxic granule exocytosis in NK cells","volume":"41","author":"Krzewski","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jcyt.2026.102077_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.691347","article-title":"Ubiquitin-like protein UBD promotes cell proliferation in colorectal cancer by facilitating p53 degradation","volume":"11","author":"Su","year":"2021","journal-title":"Front Oncol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926000393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926000393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:04:42Z","timestamp":1777586682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324926000393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1465324926000393"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102077","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing acute myeloid leukemia immunotherapy: transcriptomic profiling-guided donor selection combined with an innovative natural killer cell expansion protocol","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102077"}}